BridgeBio to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 24, 2026 at 4:30 pm ET

Core Viewpoint - BridgeBio Pharma, Inc. is set to release its fourth quarter and full year 2025 financial results and business updates on February 24, 2026, after market close, followed by a conference call to discuss these results [1]. Group 1 - The company focuses on developing medicines for genetic conditions, addressing the lack of treatment options for millions of people worldwide [3]. - BridgeBio employs a decentralized, hub-and-spoke model designed for speed, precision, and scalability in drug development [3]. - The company aims to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations [3]. Group 2 - A live webcast of the financial results presentation will be available on the BridgeBio website, with a replay accessible for 30 days post-event [2]. - Participants can register online to access the webcast [2]. Group 3 - Media and investor contacts for BridgeBio include Bubba Murarka, Executive Vice President, and Chinmay Shukla, Senior Vice President of Strategic Finance [4].